How to Raise Medical Device Startup Funding in a Harsh Investment Climate

//How to Raise Medical Device Startup Funding in a Harsh Investment Climate

How to Raise Medical Device Startup Funding in a Harsh Investment Climate

Universities and entrepreneurs are continually developing new innovations in the world of medical devices and diagnostics, but the 2008 economic crash, investor consolidation, and increased investor wariness have made funding for those ideas much harder to secure. Even before 2008, traditional venture funding for these projects was deteriorating, and purse strings have remained somewhat tight ever since.

Device and diagnostic organizations that can demonstrate real value, improve the existing standards of care, or prove that they can reduce healthcare spending are still drawing investor attention. However, even these companies have had to be creative about where they turn for funding.

This presentation will explore what types of medical device and diagnostic startups are attracting venture funding and what investors are looking for now.

Featured Speakers

  • Paul Hadden, Principal, Healthcare Royalty Partners
  • Mark Johnson, Senior Director of Surgical Services and Medical Device Evaluation, MPI Research

As our population ages and the demand for improved healthcare grows, medical device and diagnostic research companies are becoming more important than ever. In order to meet these demands, increased funding in early stage innovations and product development is needed.

Mark Johnson, MS
Senior Director of Surgical Services and Medical Device Evaluation 

By | 2014-03-17T14:53:43+00:00 May 28th, 2013|News|Comments Off on How to Raise Medical Device Startup Funding in a Harsh Investment Climate

About the Author:

MPI Research, with global headquarters in Mattawan, Mich., provides safety evaluation, discovery, bioanalytical and analytical services to the biopharmaceutical, medical device, animal health, and chemical industries. The company offers comprehensive imaging solutions including preclinical imaging, radiochemistry, and data analysis. Scientific knowledge and experience, responsiveness, integrity, trust, teamwork, and dedication to strong and enduring Sponsor relationships are the defining attributes that characterize MPI Research as a high-performance, high-quality organization that is committed to bringing safer and more effective products to the world.